{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:42:09Z","timestamp":1776472929122,"version":"3.51.2"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clinre.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T17:39:08Z","timestamp":1545845948000},"page":"e25-e32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"Eirini I.","family":"Rigopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Gyftaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinelopi","family":"Arvaniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Tsimourtou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K.","family":"Koukoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Hadjigeorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.clinre.2018.12.002_bib0005","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis \u2013 update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis -- current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2018.12.002_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2018.12.002_bib0030","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.02.029","article-title":"Use of TNF\u03b1 antagonists in refractory AIH: revealing the unforeseen","volume":"59","author":"Saitis","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0040","first-page":"9793868","article-title":"Post-infantile giant cell hepatitis with features of acute severe autoimmune hepatitis probably triggered by diclofenac in a patient with primary myelofibrosis","volume":"2018","author":"Arvaniti","year":"2018","journal-title":"Case Rep Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.clinre.2018.12.002_bib0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0055","article-title":"Hellenic Association for the Study of the Liver (HASL) clinical practice guidelines: autoimmune hepatitis","author":"Dalekos","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neuro"},{"key":"10.1016\/j.clinre.2018.12.002_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2018.12.002_bib0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2018.12.002_bib0080","article-title":"Spontaneous cirrhosis regression in an IFN-beta-induced AIH-like syndrome following drug withdrawal: Art of facts or artifacts?","volume":"3","author":"Kalafateli","year":"2016","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.clinre.2018.12.002_bib0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1191\/1352458505ms1239oa","article-title":"Autoimmune hepatitis and multiple sclerosis: a coincidental association?","volume":"11","author":"de Seze","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinre.2018.12.002_bib0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1665-2681(19)30792-6","article-title":"Interferon-beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature","volume":"14","author":"Villamil","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1572-0241.2002.05574.x","article-title":"Autoimmune hepatitis and interferon beta-1a for multiple sclerosis","volume":"97","author":"Duchini","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/1352458517692885","article-title":"Concurrent autoimmune hepatitis in multiple sclerosis","volume":"24","author":"Ca\u00e7\u00e3o","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinre.2018.12.002_bib0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"International Autoimmune Hepatitis Group. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-na\u00efve patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.clinre.2018.12.002_bib0120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2018.12.002_bib0125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2018.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","article-title":"Long-term efficacy of interferon-\u03b2-1a in relapsing MS","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0167-5699(00)01652-2","article-title":"IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation.","volume":"21","author":"Akbar","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.clinre.2018.12.002_bib0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/08916930903510971","article-title":"Type I interferon therapy and its role in autoimmunity.","volume":"43","author":"Biggioggero","year":"2010","journal-title":"Autoimmunity"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2018.12.002_bib0160","first-page":"S17","article-title":"Interferon-beta mechanisms of action in multiple sclerosis","volume":"74","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cytogfr.2016.03.013","article-title":"IFN-\u03b2 differentially regulates the function of T cell subsets in MS and EAE","volume":"30","author":"Kavrochorianou","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.clinre.2018.12.002_bib0170","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3748\/wjg.14.5474","article-title":"Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report","volume":"14","author":"Takahashi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0175","first-page":"356","article-title":"Autoimmune hepatitis after high\u2010dose intravenous methylprednisolone pulse in RR-MS","volume":"2","author":"Reu\u00df","year":"2007","journal-title":"Cent Eur J Med"},{"key":"10.1016\/j.clinre.2018.12.002_bib0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12020-016-0928-3","article-title":"Acute liver damage following intravenous glucocorticoid treatment for Graves\u2019 ophthalmopathy","volume":"54","author":"Moleti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.clinre.2018.12.002_bib0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinre.2012.10.015","article-title":"Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity","volume":"37","author":"Carrier","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinre.2017.03.008","article-title":"Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey","volume":"41","author":"Dumortier","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0195","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","article-title":"Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment","volume":"30","author":"Dalekos","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0200","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.dld.2011.02.014","article-title":"Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferonalpha 2b plus ribavirin treatment showing histological heterogeneity","volume":"43","author":"Yasui","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2018.12.002_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1665-2681(19)30914-7","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","volume":"13","author":"Rigopoulou","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0210","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.57.8.1363","article-title":"Betaferon Safety Trial (BEST) Study Group. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS","volume":"57","author":"Durelli","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/107999002753536220","article-title":"Betaferon Safety Trial (BEST) Study Group. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?","volume":"22","author":"Verdun","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.clinre.2018.12.002_bib0220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00002018-200326110-00006","article-title":"Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance","volume":"26","author":"Francis","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinre.2018.12.002_bib0225","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","author":"Zachou","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2018.12.002_bib0230","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.12.002_bib0235","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Acute liver failure study group: autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0240","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2018.12.002_bib0245","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.12.002_bib0250","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2018.12.002_bib0255","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/apt.13626","article-title":"Editorial: autoimmune hepatitis - identifying options for treatment","volume":"43","author":"Dalekos","year":"2016","journal-title":"Alim Pharmacol Therap"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118302730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118302730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:28:25Z","timestamp":1761895705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118302730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2210740118302730"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.12.002","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}